Center for Addiction Medicine

MGH Career Development Program in Substance Use and Addiction Medicine

Scholars 2018

 

Davida M. Schiff, MD, MSc

Attending, Department of Pediatrics, Massachusetts General Hospital for Children.

Instructor in Pediatrics at Harvard Medical School

Davida.Schiff@MGH.HARVARD.EDU

Dr. Schiff is a general academic pediatrician and health services researcher focused on understanding how substance use in pregnant and parenting women impacts the health of children and families. She is the Medical Director of the HOPE Clinic (Harnessing support for Opioid and substance use disorder in Pregnancy and Early childhood) at Massachusetts General Hospital, a multidisciplinary program caring for women and families with substance use disorder from the time of conception through the first two years postpartum.

Dr. Schiff completed her undergraduate training at Columbia University, medical training at the Boston University School of Medicine, pediatrics residency in the Boston Combined Residency Program at Boston Medical Center and Boston Children’s Hospital, general pediatrics research fellowship at Boston Medical Center, and master’s program in health services research from the Boston University School of Public Health. Her research is focused on improving care for families affected by substance use and her past scholarship has been published in the New England Journal of MedicineJAMAPediatricsAcademic PediatricsJournal of Substance Abuse and Treatment, and Substance Abuse, among other journals.

 

 

Kate Bentley, PhD

Clinical and Research Fellow in Psychology, Department of Psychiatry, Massachusetts General Hospital

KBENTLEY@mgh.harvard.edu    

Dr. Kate Bentley received her PhD in Clinical Psychology in 2017 from Boston University and completed her pre-doctoral internship in the Cognitive Behavioral Therapy track at Massachusetts General Hospital/Harvard Medical School. Her research is largely focused on identifying the proximal risk factors for and mechanisms of potentially life-threatening responses to intense negative affect (namely, suicidal and nonsuicidal self-injurious thoughts and behaviors) and using this information to guide the development, evaluation, and implementation of effective, scalable interventions for self-injurious thoughts and behaviors and co-occurring depressive, anxiety, and substance use disorders. Her K12 project involves testing a transdiagnostic, emotion-focused, group-based intervention for young adults with substance use disorders and co-occurring emotional distress (depression, anxiety, suicidal ideation, or nonsuicidal self-injury).

 

 

 

Sara Bates, MD

Assistant in Pediatrics, Massachusetts General Hospital

Instructor in Pediatrics, Harvard Medical School

Director, Infant Brain Center

SBATES@mgh.harvard.edu    

 

 

%d bloggers like this: